Literature DB >> 19795023

Does weight history affect fibrosis in the setting of chronic liver disease?

Thomas R Riley1, Mohammad Taheri, Ian R Schreibman.   

Abstract

AIM: To evaluate weight history in chronic liver disease and assess for associations with advanced fibrosis. Weight and Lifestyle Inventory (WALI) was used to assess lifelong weight and eating habits.
RESULTS: 38 patients had a diagnosis of nonalcoholic fatty liver disease (NAFLD) and 37 had other chronic liver disease. The body mass index (BMI) did not predict the presence of advanced fibrosis. The time with BMI over 30 kg/m2 was 19.2 years+/-15.7 with advanced fibrosis and 8.6 years+/-10.4 in the non-advanced group (p=0.002). Independent predictors of fibrosis were: 1) Non-NAFLD (OR 6.2); 2) obesity, with a BMI over 30 for more than 15 years (OR 12.4); 3) at least moderate alcohol use (OR 12.2); 4) advanced age (OR 3.3). Weight history did not impact NALFD differently from Non-NAFLD.
CONCLUSIONS: BMI over 30 for more than 15 years increases the risk of advanced fibrosis in all chronic liver diseases, on par with the risk of alcohol ingestion.

Entities:  

Mesh:

Year:  2009        PMID: 19795023

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  5 in total

1.  Mean standardized uptake value (SUVmean) and global hepatic glycolysis as potential imaging markers reflecting hepatic functional capacity: evidence from 18F-FDG PET/CT.

Authors:  X Yue; J Wang; F Ye; D Xiao
Journal:  Hippokratia       Date:  2018 Oct-Dec       Impact factor: 0.471

2.  Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression.

Authors:  Walid E Zahran; Kholoud A Salah El-Dien; Philip G Kamel; Ahmed Shawky El-Sawaby
Journal:  Indian J Clin Biochem       Date:  2012-07-14

Review 3.  Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.

Authors:  Nancy Khov; Amol Sharma; Thomas R Riley
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

4.  Protective Effects of Emodin on Lung Injuries in Rat Models of Liver Fibrosis.

Authors:  Lili Zhang; Huiying Zhang; Limin Wang; Yimin Fan; Cuiying Zhang; Xujiong Li; Dewu Han; Cheng Ji
Journal:  Open Life Sci       Date:  2019-12-31       Impact factor: 0.938

5.  Preresection obesity increases the risk of hepatobiliary complications in short bowel syndrome.

Authors:  Jon S Thompson; Rebecca A Weseman; Fedja A Rochling; Wendy J Grant; Jean F Botha; Alan N Langnas; David F Mercer
Journal:  Nutrients       Date:  2012-09-26       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.